About: http://data.cimple.eu/news-article/534035e3881915d65c5b2b19618edd2ec6a8bbde3af44ff87352c61f

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/534035e3881915d65c5b2b19618edd2ec6a8bbde3af44ff87352c61f Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	An Italian-Swiss pharmaceutical company has agreed to produce Russia's Sputnik V vaccine in Italy, the first such deal in the European Union, a trade body said Tuesday. "The vaccine will be produced from July 2021 in (pharma company) Adienne factories in Lombardy," northern Italy, a spokesman for the Italian-Russian Chamber of Commerce, Stefano Maggi, told AFP. "Ten million doses will be produced between July 1 and January 1, 2022," he added, describing it as the "first agreement on the European level for the production on EU territory of the Sputnik vaccine". Several EU countries have already begun distributing Sputnik V, but it has yet to be approved by the bloc's medicines regulator. Last week the Amsterdam-based European Medicines Agency launched a rolling review of the Russian vaccine, a key step towards being approved as the first non-Western jab to be used against the coronavirus across the 27-nation bloc. "If the vaccine is not authorised in Europe by July 1, the doses produced (in Italy) will be bought by the Russian sovereign fund and distributed in countries where the Sputnik vaccine is authorised," Maggi said. Italy's health ministry declined to comment on the deal. Adienne was not immediately available and the northern Italian region of Lombardy said it had learned about it through media reports. But it was welcomed by Attilio Fontana, president of Lombardy, which has been since the start the epicentre of the pandemic in Italy. If the EMA approves the Russian jab, "it could be an important solution to find vaccines that are still a bit scarce," he said. The EU has so far authorised three vaccines: the US-German Pfizer/BioNTech jab, US firm Moderna's shot, and the British-Swedish AstraZeneca/Oxford vaccine. The bloc is set to decide on the one-shot Johnson & Johnson vaccine on March 11, while jabs by Novavax and CureVac are also under rolling review. glr/ar/aa/kjl
schema:headline	Italy factory to produce Sputnik vaccine, first in EU: trade body
schema:mentions	Novavax Lombardy Epicenter Maggi Agence France-Presse European Medicines Agency Pharmaceutical industry Johnson & Johnson Sputnik 1 Jab University of Oxford AstraZeneca Italy European Union Russia Pandemic Russian language Pfizer Vaccine United States Severe acute respiratory syndrome coronavirus 2 Attilio Fontana BBC Radio London Multivibrator CureVac
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-09 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	79 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software